The following table provides an overview of the latest patents of Bayer Healthcare Llc that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3230316Jan 5, 2022Treatment Of Age Related Macular Degeneration With A Small Active Choroidal Neovascularization Lesion6
EP2772500Dec 25, 2019Site-Directed Modification Of Fviii1
EP2109394May 23, 2018Analyte-Testing Device1